BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Purow B. Notch inhibitors as a new tool in the war on cancer: a pathway to watch. Curr Pharm Biotechnol. 2009;10:154-160. [PMID: 19199947 DOI: 10.2174/138920109787315060] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Dees C, Zerr P, Tomcik M, Beyer C, Horn A, Akhmetshina A, Palumbo K, Reich N, Zwerina J, Sticherling M. Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis. Arthritis Rheum. 2011;63:1396-1404. [PMID: 21312186 DOI: 10.1002/art.30254] [Cited by in Crossref: 86] [Cited by in F6Publishing: 85] [Article Influence: 8.6] [Reference Citation Analysis]
2 Gagliardini E, Perico N, Rizzo P, Buelli S, Longaretti L, Perico L, Tomasoni S, Zoja C, Macconi D, Morigi M, Remuzzi G, Benigni A. Angiotensin II contributes to diabetic renal dysfunction in rodents and humans via Notch1/Snail pathway. Am J Pathol 2013;183:119-30. [PMID: 23707238 DOI: 10.1016/j.ajpath.2013.03.025] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
3 Liu RT, Zou LB, Fu JY, Lu QJ. Effects of liquiritigenin treatment on the learning and memory deficits induced by amyloid beta-peptide (25-35) in rats. Behav Brain Res 2010;210:24-31. [PMID: 20117143 DOI: 10.1016/j.bbr.2010.01.041] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
4 Dantonio PM, Klein MO, Freire MRVB, Araujo CN, Chiacetti AC, Correa RG. Exploring major signaling cascades in melanomagenesis: a rationale route for targetted skin cancer therapy. Biosci Rep 2018;38:BSR20180511. [PMID: 30166456 DOI: 10.1042/BSR20180511] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
5 Pierfelice TJ, Schreck KC, Dang L, Asnaghi L, Gaiano N, Eberhart CG. Notch3 activation promotes invasive glioma formation in a tissue site-specific manner. Cancer Res 2011;71:1115-25. [PMID: 21245095 DOI: 10.1158/0008-5472.CAN-10-0690] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
6 Pajvani UB, Accili D. The new biology of diabetes. Diabetologia 2015;58:2459-68. [PMID: 26248647 DOI: 10.1007/s00125-015-3722-5] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 9.2] [Reference Citation Analysis]
7 Liu J, Fan H, Ma Y, Liang D, Huang R, Wang J, Zhou F, Kan Q, Ming L, Li H, Giercksky KE, Nesland JM, Suo Z. Notch1 is a 5-fluorouracil resistant and poor survival marker in human esophagus squamous cell carcinomas. PLoS One 2013;8:e56141. [PMID: 23409141 DOI: 10.1371/journal.pone.0056141] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
8 Gonzalez C. Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics. Nat Rev Cancer 2013;13:172-83. [PMID: 23388617 DOI: 10.1038/nrc3461] [Cited by in Crossref: 183] [Cited by in F6Publishing: 163] [Article Influence: 22.9] [Reference Citation Analysis]
9 Bennani-Baiti IM, Aryee DN, Ban J, Machado I, Kauer M, Mühlbacher K, Amann G, Llombart-Bosch A, Kovar H. Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma. J Pathol 2011;225:353-63. [PMID: 21984123 DOI: 10.1002/path.2966] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
10 Belyea B, Kephart JG, Blum J, Kirsch DG, Linardic CM. Embryonic signaling pathways and rhabdomyosarcoma: contributions to cancer development and opportunities for therapeutic targeting. Sarcoma 2012;2012:406239. [PMID: 22619564 DOI: 10.1155/2012/406239] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
11 Julian E, Hallahan AR, Wainwright BJ. RBP-J is not required for granule neuron progenitor development and medulloblastoma initiated by Hedgehog pathway activation in the external germinal layer. Neural Dev 2010;5:27. [PMID: 20950430 DOI: 10.1186/1749-8104-5-27] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
12 Pajvani UB, Shawber CJ, Samuel VT, Birkenfeld AL, Shulman GI, Kitajewski J, Accili D. Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner. Nat Med. 2011;17:961-967. [PMID: 21804540 DOI: 10.1038/nm.2378] [Cited by in Crossref: 130] [Cited by in F6Publishing: 124] [Article Influence: 13.0] [Reference Citation Analysis]
13 Julian E, Dave RK, Robson JP, Hallahan AR, Wainwright BJ. Canonical Notch signaling is not required for the growth of Hedgehog pathway-induced medulloblastoma. Oncogene 2010;29:3465-76. [DOI: 10.1038/onc.2010.101] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
14 Goriki A, Seiler R, Wyatt AW, Contreras-sanz A, Bhat A, Matsubara A, Hayashi T, Black PC. Unravelling disparate roles of NOTCH in bladder cancer. Nat Rev Urol 2018;15:345-57. [DOI: 10.1038/s41585-018-0005-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
15 Luistro L, He W, Smith M, Packman K, Vilenchik M, Carvajal D, Roberts J, Cai J, Berkofsky-Fessler W, Hilton H. Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties. Cancer Res. 2009;69:7672-7680. [PMID: 19773430 DOI: 10.1158/0008-5472.can-09-1843] [Cited by in Crossref: 142] [Cited by in F6Publishing: 78] [Article Influence: 11.8] [Reference Citation Analysis]
16 Pannuti A, Foreman K, Rizzo P, Osipo C, Golde T, Osborne B, Miele L. Targeting Notch to target cancer stem cells. Clin Cancer Res 2010;16:3141-52. [PMID: 20530696 DOI: 10.1158/1078-0432.CCR-09-2823] [Cited by in Crossref: 318] [Cited by in F6Publishing: 179] [Article Influence: 28.9] [Reference Citation Analysis]
17 Christopoulos PF, Gjølberg TT, Krüger S, Haraldsen G, Andersen JT, Sundlisæter E. Targeting the Notch Signaling Pathway in Chronic Inflammatory Diseases. Front Immunol 2021;12:668207. [PMID: 33912195 DOI: 10.3389/fimmu.2021.668207] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Tang J, Zhou H, Liu J, Liu J, Li W, Wang Y, Hu F, Huo Q, Li J, Liu Y, Chen C. Dual-Mode Imaging-Guided Synergistic Chemo- and Magnetohyperthermia Therapy in a Versatile Nanoplatform To Eliminate Cancer Stem Cells. ACS Appl Mater Interfaces 2017;9:23497-507. [PMID: 28661121 DOI: 10.1021/acsami.7b06393] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
19 Rennel ES, Harper SJ, Bates DO. Therapeutic potential of manipulating VEGF splice isoforms in oncology. Future Oncol 2009;5:703-12. [PMID: 19519209 DOI: 10.2217/fon.09.33] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
20 Chen W, Hu GH. Biomarkers for enhancing the radiosensitivity of nasopharyngeal carcinoma. Cancer Biol Med 2015;12:23-32. [PMID: 25859408 DOI: 10.7497/j.issn.2095-3941.2014.0015] [Cited by in F6Publishing: 19] [Reference Citation Analysis]
21 Chen YX, Weng ZH, Zhang SL. Notch3 regulates the activation of hepatic stellate cells. World J Gastroenterol 2012; 18(12): 1397-1403 [PMID: 22493555 DOI: 10.3748/wjg.v18.i12.1397] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]